Additionally, NaA stimulates the secretion of glucagon-like peptide 1 (GLP-1) and peptide YY (PYY) from endocrine cells through G-protein-coupled receptor transport, thereby regulating appetite and food intake, improving lipid metabolism to alleviate NAFLD [15]. The gene discussed is GCG; the disease is metabolic dysfunction-associated steatotic liver disease.